<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[12, 16] lipid-lowering treatment<br>[17, 20] diet, clofibrate<br>[21, 23] niceritrol.<br>[81, 90] clofibrate or niceritrol, a nicotinic acid ester,<br>[112, 117] diet, clofibrate and niceritrol<br>[372, 373] clofibrate<br></td>
<td width=33%>
[12, 16] lipid-lowering treatment<br>[17, 20] diet, clofibrate<br>[21, 23] niceritrol.<br>[81, 90] clofibrate or niceritrol, a nicotinic acid ester,<br>[112, 117] diet, clofibrate and niceritrol<br>[372, 373] clofibrate<br></td>
<td width=33%>
[12, 23] lipid-lowering treatment with diet, clofibrate and niceritrol.<br>[50, 54] lipid-lowering treatment<br>[71, 72] diet<br>[81, 97] clofibrate or niceritrol, a nicotinic acid ester, was added in a randomized order.<br>[109, 117] combined treatment with diet, clofibrate and niceritrol<br>[203, 204] diet<br>[208, 211] clofibrate while niceritrol<br>[223, 225] Clofibrate treatment<br>[372, 374] clofibrate treatment<br>[385, 387] diet.<br></td>
</tr>
